New predictive software integrated into an insulin pump can reduce time spent in hypoglycaemia compared with sensor-augmented pumps in type 1 disease. Medical device firm Tandem Diabetes Care has ...

Tandem Diabetes Care has announced that its t:slim X2 insulin pump, featuring Control-IQ automated insulin delivery technology, received approval for use with the ultra-rapid-acting insulin ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

This impressive performance was largely attributed to the successful launch of the company's Mobi insulin pump system. The Mobi launch has been a significant driver of growth for Tandem ...

The variables assessed included glycemic control (glycohemoglobin and blood glucose), total insulin dose, and body weight. Because the interaction effect of these covariates with time (pre- vs.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery ...

Insulin pumps are a medical device used by people ... Traditionally they have involved a canula and separate connected pump, but more recent models have taken the form of a patch with a pump ...

It’s obviously a serious occurrence for an insulin pump to be affected by anything, and it sounds as though the radio amateur concerned has done the right thing. But it’s clear that something ...

Objective: To evaluate the safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Research Design and Methods: All 95 patients who began insulin pump ...

Tandem Diabetes Care reported a strong second quarter in 2024, outperforming expectations in both sales and EBITDA. This impressive performance was largely attributed to the successful launch of the ...